Endogenous technological change in medicine and its impact on healthcare costs: Evidence from the pharmaceutical market in Taiwan

European Journal of Health Economics

Volumn 14, Issue 2, 2013, Pages 287-295

  Hsieh, Chee Ruey ^a   Liu, Ya Ming ^b   Chang, Chia Lin ^c  

^a INSTITUTE OF ECONOMICS   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Health expenditure; New drugs; Simultaneous equation model; Technological innovation

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTINEOPLASTIC AGENT; IMMUNOMODULATING AGENT; PRESCRIPTION DRUG; VACCINE;

ALTERNATIVE HYPOTHESIS; ARTICLE; COST CONTROL; DIABETES MELLITUS; DIABETIC PATIENT; DRUG COST; DRUG IDENTIFICATION; DRUG INDUSTRY; ECONOMIC DEVELOPMENT; HEALTH CARE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HOSPITALIZATION COST; HUMAN; INSURANCE; LIFE EXPECTANCY; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; MEDICARE; MEDICINE; OUTPATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; REIMBURSEMENT; SOCIOECONOMICS; TAIWAN;

DIFFUSION OF INNOVATION; ECONOMICS, PHARMACEUTICAL; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; MODELS, ECONOMIC; NATIONAL HEALTH PROGRAMS; TAIWAN;

EID: 84880698811     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-011-0370-7     Document Type: Article

References (23)

1. Acemoglu, D.; Linn, J.: Market size in innovation: theory and evidence from the pharmaceutical industry. Q. J. Econ. 119(3), 1049-1090 (2004)
2. Anindya, S.: Is health care a luxury? New evidence from OECD data. Int. J. Health Care Finance Econ. 5(2), 147-164 (2005)
3. Baltagi, B.H.; Moscone, F.: Health care expenditure and income in the OECD reconsidered: evidence from panel data. Econ. Model. 27, 804-811 (2010)
4. Carrion-i-Silvestre, J.L.: Health care expenditure and GDP: are they broken stationary? J. Health Econ. 24, 839-854 (2005)
5. Cutler, D.M.; McClellan, M.: Is technological change in medicine worth it? Health Aff. 20, 11-29 (2001)
6. Finkelstein, A.: Static and dynamic effects of health policy: evidence from the vaccine industry. Q. J. Econ. 119(2), 527-564 (2004)
7. Finkelstein, A.: The aggregate effects of health insurance: evidence from the introduction of medicare. Q. J. Econ. 122(1), 1-37 (2007)
8. Fuchs, V.R.: Economics, values, and health care reform. Am. Econ. Rev. 86(1), 1-24 (1996)
9. Gerdtham, U.G.; Jönsson, B.: International comparisons on health expenditure: theory, data and econometric analysis. In: Culyer, A.J.; Newhouse, J.P. (eds.) Handbook of health economics, pp. 11-53. Elsevier, North Holland (2000)
10. Hall, R.E.; Jones, C.I.: The value of life and the rise in health spending. Q. J. Econ. 122(1), 39-72 (2007)
11. Hausman, J.A.: Specification tests in econometrics. Econometrics 46, 1251-1271 (1978)
12. Kleiman, E.: The determinants of national outlay on health. In: Perlman, M. (ed.) The economics of health and medical care. Macmillan, London (1974)
13. Lichtenberg, F.R.; Virabhak, R.: Pharmaceutical embodied technical progress, longevity, and quality of life: drugs as 'equipment for your health'. National Bureau of Economic Research, Cambridge, MA (2002)
14. Lichtenberg, F.R.: Pharmaceutical innovations, mortality reduction, and economic growth. In: Murphy, K.M.; Topel, R.H. (eds.) Measuring the gains from medical research: an economic approach. University of Chicago Press, Chicago (2003)
15. Lichtenberg, F.R.: The impact of new drug launches on longevity: evidence from longitudinal, disease-level data from 52 countries, 1982-2001. Int. J. Health Care Finance Econ. 5(1), 47-73 (2005)
16. Lichtenberg, F.R.: The quality of medical care, behavior risk factors, and longevity growth. Int. J. Health Care Finance Econ. 11, 1-34 (2011)
17. Liu, Y.M.; Hsieh, C.R.: New drugs and the growth of health expenditure: evidence from diabetic patients in Taiwan. Health Econ. (2012). doi: 10.1002/hec.1724
18. Liu, Y.M.; Kao Yang, Y.H.; Hsieh, C.R.: Regulation and competition in the Taiwanese pharmaceutical market under national health insurance. Mimeo (2011)
19. Newhouse, J.P.: Medical care costs: how much welfare loss? J. Econ. Perspect. 16(3), 3-21 (1992)
20. Newhouse, J.P.: Medical care expenditures: a cross-national survey. J. Hum. Res. 12, 115-125 (1977)
21. Okunade, A.A.; Murthy, V.N.R.: Technology as a 'major driver' of health care costs: a cointegration analysis of the Newhouse conjecture. J. Health Econ. 21, 147-159 (2002)
22. Papageorgiou, C.; Savvides, A.; Zachariadis, M.: International medical technology diffusion. J. Int. Econ. 72, 409-427 (2007)
23. Smith, S.; Newhouse, J.P.; Freeland, M.S.: Income, insurance and technology: why does health spending outpace economic growth? Health Aff. 28(5), 1276-1284 (2009)